Lv1
40 积分 2025-07-11 加入
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
5天前
已完结
Advances in Multiple Sclerosis
6天前
已完结
Depletion of B Cells in Murine Lupus: Efficacy and Resistance
1个月前
已完结
Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy
1个月前
已完结
Progressive multiple sclerosis: Six trials to watch
2个月前
已关闭
Localized PD-1 CAR T therapy reprograms neuroinflammation
2个月前
已完结
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis
3个月前
已完结
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
3个月前
已完结
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
3个月前
已完结
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
3个月前
已完结
皖公网安备34019202002308
